The therapy of osteogenic sarcoma: current status and thoughts for the future.
D000367:Age Factors; D000368:Aged; D001859:Bone Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D012516:Osteosarcoma / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D011379:Prognosis; D012737:Sex Factors; D013997:Time Factors
D004317:Doxorubicin; D008727:Methotrexate